Virtuos Lyograft
-
Biologics
Orthofix and MTF Biologics Recognized with 2022 Spine Technology Award for Virtuos Lyograft – a First-of-Its-Kind, Shelf-Stable and Complete Autograft Substitute for Spine and Orthopedic Procedures
LEWISVILLE, TEXAS — October 12, 2022 /OrthoSpineNews/ — Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and…
Read More » -
Biologics
Orthofix Announces First Clinical Use of Virtuos Lyograft – a First-of-Its-Kind, Shelf-Stable and Complete Autograft Substitute for Spine and Orthopedic Procedures
LEWISVILLE, TEXAS – July 26, 2022 /OrthoSpineNews/ — Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and…
Read More »